Canine Parvovirus Mab
12 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
9
Deaths Reported
7500.0%
Death Rate
Active Ingredients
Canine Parvovirus Mab
Administration Routes
IntravenousUnknownParenteral
Species Affected
Dog 12
Most Affected Breeds
Poodle (unspecified) 3
Dog (unknown) 2
Collie - Border 2
Shepherd Dog - Belgian Malinois 1
Sheepdog - Shetland 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Coonhound - Bluetick 1
Pointing Dog - German Short-haired 1
Most Reported Reactions
Death 9
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 7
Lateral recumbency 4
Death by euthanasia 3
Unclassifiable adverse event 3
Vomiting 2
Lethargy (see also Central nervous system depression in Neurological) 2
Lack of efficacy - NOS 2
Other abnormal test result NOS 2
Behavioural disorder NOS 2
Diarrhoea 2
Hypoglycaemia 2
Outcome Breakdown
Died
9 (42.9%)
Ongoing
4 (19.0%)
Outcome Unknown
4 (19.0%)
Euthanized
3 (14.3%)
Recovered/Normal
1 (4.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.